Abstract

INTRODUCTIONRelatively few, mainly cross-sectional, studies have examined the relationship between smoking cessation and metabolic syndrome (MetS). In particular, information on smoking cessation after MetS is limited. This study aimed to investigate the probability of smoking cessation after the onset of MetS.METHODSIn this study we used cohort data from a rural area of Korea and extracted the data of 1054 smokers who were identifiable at baseline and were followed up. Of these, 1041 individuals were selected. Descriptive statistical analyses were performed to identify the basic characteristics of smokers. Multiple logistic regression was performed to determine the association between changes in MetS and smoking cessation.RESULTSThe probability of smoking cessation was 1.84 times higher in the newly developed MetS cohort than in the reference group (without MetS at any time point), and it was 1.61 times higher in the persistent MetS cohort than in the reference group, with both probabilities being significant.CONCLUSIONSWe found that patients with MetS were more likely to quit smoking than those without MetS. However, intervention is still needed, as numerous patients with MetS continued to smoke. Interventions that actively involve medical institutions or organizations are among the most effective approaches to promote smoking cessation in patients with MetS. In particular, women, farmers and current drinkers should be prioritized.

Highlights

  • Few, mainly cross-sectional, studies have examined the relationship between smoking cessation and metabolic syndrome (MetS)

  • For patients with MetS who are at high risk of serious diseases such as stroke and ischemic heart disease, smoking cessation is necessary for survival[17], and smokers with MetS are strongly recommended to stop smoking[18,19]

  • Smoking cessation has been strongly recommended for MetS patients

Read more

Summary

Introduction

Few, mainly cross-sectional, studies have examined the relationship between smoking cessation and metabolic syndrome (MetS). Metabolic syndrome (MetS) is another currently important risk factor for disease. MetS refers to the simultaneous occurrence of abdominal obesity, hypertension, dyslipidemia, and impaired fasting blood glucose in a person, and is known to increase the risk of cardiovascular disease and type 2 diabetes and is related to increased mortality[6,7]. There have been relatively few, mainly cross-sectional, studies on the relationship between smoking cessation and MetS. Smoking cessation has a positive effect on almost all aspects of health, including MetS It reduces blood clotting, and the heart can supply blood and oxygen to the whole body with less burden, and reduces the risk of myocardial infarction in individuals with other risk factors, especially hypertension, elevated blood cholesterol, being overweight, and diabetes[16]. For patients with MetS who are at high risk of serious diseases such as stroke and ischemic heart disease, smoking cessation is necessary for survival[17], and smokers with MetS are strongly recommended to stop smoking[18,19]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call